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The core pluripotency factor Oct4 plays key roles in
somatic cell reprogramming through transcriptional
control. Here, we profile Oct4 occupancy, epigenetic
changes, and gene expression in reprogramming.
We find that Oct4 binds in a hierarchical manner to
target sites with primed epigenetic modifications.
Oct4 binding is temporally continuous and seldom
switches between bound and unbound. Oct4 occu-
pancy inmost of promoters ismaintained throughout
the entire reprogramming process. In contrast, so-
matic cell-specific enhancers are silenced in the
early and intermediate stages, whereas stem cell-
specific enhancers are activated in the late stage in
parallel with cell fate transition. Both epigenetic
remodeling andOct4 binding contribute to the hyper-
dynamic enhancer signature transitions. The hierar-
chical Oct4 bindings are associated with distinct
functional themes at different stages. Collectively,
our results provide a comprehensive molecular
roadmap of Oct4 binding in concert with epigenetic
rearrangements and rich resources for future reprog-
ramming studies.
INTRODUCTION
Somatic cells can be reverted to a pluripotent stem cell state by
forced expression of Yamanaka factors Oct4, Sox2, Klf4, and
c-Myc (OSKM) (Takahashi et al., 2007; Takahashi and Yama-
naka, 2006). Understanding the underlying mechanisms driving
this process is crucial, not only for potential clinical applications
requiring high-quality induced pluripotent stem cells (iPSCs),
but also for answering fundamental questions regarding cell
plasticity, cell identity, and cell fate determination. Recently,
advances have been made in defining the cascade of transcrip-1540 Cell Reports 14, 1540–1554, February 16, 2016 ª2016 The Authtional and epigenetic events that result in cell fate transitions
(Buganim et al., 2013; Hussein et al., 2014). During reprogram-
ming, cells go through three distinct phases termed initiation,
maturation, and stabilization (Samavarchi-Tehrani et al.,
2010). The initiation phase is marked by a mesenchymal-to-
epithelial transition (MET) and upregulation of proliferation
genes (Li et al., 2010; Samavarchi-Tehrani et al., 2010). In the
subsequent maturation phase, the somatic cell program is
further repressed and early pluripotency markers are activated.
The hierarchical activation of the core pluripotency circuitry is
initiated by the stochastic activation of key pluripotency
markers (Buganim et al., 2012; Polo et al., 2012). However,
cells at this phase are not fully reprogrammed until a transgene
repression-dependent transition to the stabilization phase has
occurred (Golipour et al., 2012). Chromatin remodeling also
plays a very important role in reprogramming, as it provides
the epigenetic basis for transcriptional regulation. Extensive
studies that profiled DNA methylation and key histone modifi-
cations (HMs) during reprogramming have described the role
of epigenetic rearrangements in resetting somatic cells to an
embryonic stem cell (ESC)-like state (Hussein et al., 2014;
Koche et al., 2011; Lee et al., 2014; Mikkelsen et al., 2007;
Polo et al., 2012).
In ESCs, pluripotency is established and maintained through
highly interconnected protein-DNA and protein-protein net-
works. Genome-wide occupancy studies have revealed that
pluripotency transcription factors (TFs) often co-occupy regula-
tory elements and coordinate to control gene expression
through various TF combinations (Boyer et al., 2005; Chen
et al., 2008; Kim et al., 2008; Loh et al., 2006; Sridharan
et al., 2009). These factors form a transcriptional regulatory hi-
erarchy to control the ESC-specific expression program, both
by activating genes critical for the maintenance of pluripotency
and by repressing lineage-specific genes (Jaenisch and Young,
2008; Orkin and Hochedlinger, 2011; Young, 2011). Further-
more, a recent study found that a catalog of super-enhancers
(SEs), which are densely co-bound by the core pluripotency
factors and Mediator, define ESC identity (Whyte et al., 2013).ors
Figure 1. Mouse Secondary Reprogram-
ming System
(A) Outline of design for secondary reprogramming
and cell sample collections. Dox is removed after
day 15. Details are in the Supplemental Experi-
mental Procedures.
(B) Representative microscopy images show cell
morphology changes during 2 induction. Scale
bar, 200 mm.
(C) Stacked bar chart summarizing FACS analysis
by surface markers and Oct4-GFP expression
during 2 induction. Data are presented as the
mean ± SEM (nR 3).
(D) Principal-component analysis (PCA) of gene
expression profiles of cell populations at indicated
reprogramming time points from this study and
two other published studies is shown.
(E) Unsupervised hierarchical clustering of gene
expression profiles well defines known phases of
reprogramming.
(F) The number of differentially expressed (DE)
genes identified between successive time points
during secondary reprogramming. The enriched
GO terms for DE genes are listed in Figure S1C.Previous studies revealed distinct binding patterns for Yama-
naka factors OSKM during different stages of reprogramming
(Soufi et al., 2012; Sridharan et al., 2009). Despite these ad-
vances, previous studies focused solely on the initial stage of
reprogramming or pre-iPSCs/iPSCs. The occupancy dynamics
of the core TFs in the genome during somatic cell reprogram-
ming remain unexplored. In addition to TFs, the core pluripo-
tency factors interacted with diverse chromatin-remodeling
and -modifying complexes to regulate chromatin organization
and gene expression during reprogramming (Orkin and Ho-
chedlinger, 2011; Papp and Plath, 2013). However, the inter-
play between epigenetic rearrangements and the binding of
the core TFs remains elusive.Cell Reports 14, 1540–1554, FTo address the aforementioned gaps in
knowledge, we generated maps of
genome-wide exogenous/total Oct4 oc-
cupancy and four core HMs (H3K4me1/
H3K4me3/H3K27ac/H3K27me3) at nine
defined time points spanning the initia-
tion, maturation, and stabilization phases
of mouse somatic cell reprogramming
using a doxycycline (Dox)-inducible
secondary reprogramming system. We
aimed to elucidate the dynamic binding
patterns of the core pluripotency factor
Oct4 and the selected key HMs, and their
interplay, during reprogramming. In com-
bination with gene expression profiles,
our results demonstrate that Oct4 binds
to target sites with primed epigenetic
rearrangements in a temporally hierarchi-
cal manner during somatic cell reprog-
ramming, and the hierarchical Oct4bindings are associated with distinct functional themes at
different stages.
RESULTS
Establishment and Verification of a Rapid and Stable
3FLAG-OSKM 2 Reprogramming System
To explore the fundamental role of the core pluripotency factor
Oct4 in somatic cell reprogramming, we set up a modified
tetO-inducible secondary reprogramming system (Brambrink
et al., 2008; Kang et al., 2009; Stadtfeld et al., 2008; Figure 1A).
We mainly modified our reprogramming system in two perspec-
tives as follows: (1) in addition to Dox, the induction mediumwasebruary 16, 2016 ª2016 The Authors 1541
supplemented with vitamin C (Vc) to improve reprogramming
efficiency (Esteban et al., 2010); and (2) exogenous Oct4
was labeled with a 33 FLAG tag to distinguish it from endoge-
nous Oct4.
We observed prominent morphological changes in the first
3 days of reprogramming, and cells began to aggregate on
day 5. Oct4-GFP+ cell colonies emerged on day 7 and increased
over time (Figure 1B). Fluorescence-activated cell sorting (FACS)
analysis of progressive reprogramming cells revealed that our
reprogramming system is rapid and efficient. The reprogram-
ming kinetics of our system showed a transition from a Thy1+
to Thy1, SSEA1+, and Oct4-GFP+ states in turn (Figures 1C
and S1A), which is consistent with the previously reported
Col1a1-tetO-OKSM transgenic reprogramming system (Polo
et al., 2012).
Gene Expression Profiling during Reprogramming
Progress
Principal-component analysis (PCA) of gene expression profiles
of bulk reprogramming intermediate cells showed a transcrip-
tomic progression trajectory similar to that of sorted cells (Polo
et al., 2012). In contrast, the bulk of reprogramming intermediate
cells in another study (Mikkelsen et al., 2008) were clustered with
Thy1+ cells (Figure 1D). Unsupervised clustering of gene expres-
sion data defined three phases of reprogramming, as has been
reported previously (Samavarchi-Tehrani et al., 2010): days 1–7
as the first-phase initiation; days 11–15 as the second-phase
maturation; and day 18 and iPSC as the third-phase stabilization
(Figure 1E).
Consistent with a previous study (Polo et al., 2012), our results
showed two waves of gene expression changes, at the begin-
ning and the intermediate stages of reprogramming (Figure 1F).
The first wave took place between days 0 and 1, whereas the
second wave emerged between days 7 and 11, toward the
end of reprogramming. The first wave may reflect the immediate
response to exogenous OSKM expression, which included
upregulation of ribosomal/RNA-processing, cell-cycle, and
DNA-repair-pathway genes and downregulation of cell adhe-
sion-related genes. This prepares the cells for enhanced cell pro-
liferation and MET. The second wave was characterized by early
activation of pluripotency genes and suppression of the lineage-
specific program (Figure S1C). Note that the augmentation of
differentially expressed genes between days 15 and 18 was
likely due to the withdrawal of Dox after day 15, and it likely rep-
resented transcriptomic modulation toward a well-defined
pluripotent state at the stabilization phase (Golipour et al.,
2012; Tonge et al., 2014). Furthermore, we examined some
representative genes from various categories and confirmed
that their expression patterns (Figure S1B) were typical, as in
the previous study (Polo et al., 2012). Interestingly, Fbxo15 is a
later marker in our system whereas it is an early marker in other
systems. This difference is likely the effect of different stoichiom-
etry of exogenous factors between reprogramming systems.
Taken together, we established a rapid and efficient 2 reprog-
ramming system suitable for dissecting progressive molecular
changes during reprogramming.
Next, we collected bulk cell populations at different reprog-
ramming time points and performed chromatin immunoprecipi-1542 Cell Reports 14, 1540–1554, February 16, 2016 ª2016 The Authtation sequencing (ChIP-seq) of Oct4 andmultiple HMs. Notably,
although our data suggest that our reprogramming system is
relatively efficient and behaves like enriched cell populations,
the heterogeneity of reprogramming cells may limit the detection
of minority binding events, which occur only in small sets of cells
but are important for reprogramming.
Turnover between Exogenous and Endogenous Oct4
Binding during Reprogramming
A landscape of exogenous and total (endogenous and exoge-
nous) Oct4 binding in the genome during reprogramming was
generated by ChIP-seq using FLAG and Oct4 antibodies,
respectively. Both total and exogenous Oct4-binding signals
formed a unique peak around transcription start sites (TSSs)
on day 1, whereasOct4 signals around TSSswere close to back-
ground on day 0 (Figure S2A). De novo motif discovery identified
Oct4-binding motif in both datasets that resembled the canoni-
cal Oct4 motif in the JASPAR database (Bryne et al., 2008; Fig-
ure S2B). In addition, clustering of total Oct4-binding profiles at
specified time points gave rise to the same three phases of re-
programming as the clustering by gene expression profiles (Fig-
ures S2C and 1E). Taken together, these data suggest that our
Oct4-binding profiles represent its bona fide target sites and
reflect the kinetics of reprogramming.
The expression of endogenous Oct4 is gradually activated
during reprogramming. However, when the endogenous Oct4
is expressed and its weight in the total Oct4 remain elusive. To
address this, we compared exogenous and total Oct4-binding
data. First, we found exogenous and total Oct4-binding peaks
largely overlapped, indicating that they basically bound to the
same genomic loci as expected (Figure S2D). Subsequently,
we used a 1-kb window to scan the genome and calculate the
total and exogenous Oct4-binding signals at indicated time
points during reprogramming. Intriguingly, pairwise correlation
analysis of Oct4 occupancy showed that exogenous and total
Oct4-binding profiles were highly correlated from day 1 until
day 7, whereas correlations decreased from day 11 until the
end of reprogramming. (Figure 2A). The decline of correlation
from day 11 coincided with the activation of endogenous Oct4,
as demonstrated by gene expression analysis at both the
mRNA and protein levels (Figures 2B and 2C). Notably, following
the removal of Dox, the correlation on day 18 showed a pro-
nounced drop. Together, these data suggest that our ChIP
data present well the timing of endogenous Oct4 activation
and its increasing weight in the total Oct4 during reprogramming.
Characteristics of Different Clusters of Oct4-Binding
Sites
To investigate patterns of Oct4 binding in the reprogramming
process, we clustered total Oct4 peaks by K-means and ob-
tained seven Oct4-binding clusters (Figure 2D). Oct4 extensively
bound to the genome at the beginning of reprogramming (clus-
ters 1, 4, 5, and 6). Oct4 occupancy in cluster 1 target sites pre-
cipitously dropped to the basal level after day 7, whereas Oct4
occupancy in cluster 5 and 6 sites gradually decreased at late
stage (around day 18). In contrast, cluster 4 sites were constantly
occupied by Oct4 during the entire reprogramming process.
However, only a small portion of sites (clusters 2 and 3) wereors
Figure 2. Oct4-Binding Patterns along Reprogramming
(A) Correlation between exogenous and total Oct4 occupancy across the genome during reprogramming. The genome was scanned with a 1-kb window.
(B) The qRT-PCR analysis showing transcription levels of exogenous, total, and endogenous Oct4 during 2 induction. Gene expression level is normalized to the
housekeeping control gene Hprt and compared to day 0. Data are presented as the mean ± SEM (n = 3).
(C)Western blotting showing protein levels of exogenous and total Oct4 during 2 reprogramming. Exogenous and total Oct4 levels were detected with FLAG and
Oct4 antibodies, respectively. Protein levels were normalized to Tubulin.
(D) K-means (k = 7) clustering of total Oct4-binding peak occupancy at indicated reprogramming time points is shown.
(E) Frequency of each cluster of total Oct4 peaks within specified ranges of distance to TSS is shown.
(F) Distribution of total Oct4-binding sites with respect to the TSS at different reprogramming time points is shown.
(G) Enrichment analysis of TF motifs in each cluster of total Oct4 peaks. Gene expression profiles for selected TFs are provided in Figure S2G.occupied by Oct4 at the intermediate or late stage of reprogram-
ming, and these sites remained occupied until the end of reprog-
ramming. Additionally, a small group of sites (cluster 7) were
transiently occupied by Oct4 from day 7 to day 15. As expected,
when we examined the exogenous Oct4-binding signals on
these seven clusters of total Oct4-binding sites, it turned out
the same patterns (Figure S2E).
To better understand the biological function of Oct4-binding
events, we examined whether there was bias in the genomic
locations of each cluster of Oct4-binding sites. Intriguingly,
cluster 4, 5, and 6 Oct4-binding sites were significantly
enriched in promoter regions, whereas cluster 1 sites wereCell Rdepleted in promoter regions. Other clusters of sites were rela-
tively randomly located in the genome (Figure S2F). Approxi-
mately 50% of cluster 4 sites and 25% of cluster 5 and 6 sites
were located within 5 kb of the TSSs, while >80% of remaining
clusters of sites were located more than 5 kb from the TSSs. Of
note, >70% of cluster 1 sites were located beyond 50 kb of
TSSs (Figure 2E). Moreover, there was a tendency for Oct4 to
bind to upstream regions distal from the TSS in the early stage
(day 1 to day 7), whereas its binding skewed toward regions
more proximal to the TSS at the late stage (day 11 to iPSC)
(Figure 2F), which was in agreement with the previous finding
(Soufi et al., 2012).eports 14, 1540–1554, February 16, 2016 ª2016 The Authors 1543
Next, we searched for enriched TF-binding motifs within each
cluster of Oct4-binding sites using themotif search tool Cistrome
SeqPos (Liu et al., 2011). As expected, motifs of the TFs (Oct4,
Sox2, Nanog, and Smad), which form the core pluripotency
module, were enriched in all Oct4-binding sites (Figure 2G). Motif
of another pluripotency TF Klf4 was depleted only in cluster 1
sites. In contrast, cluster 2 and 3 sites showed significant motif
enrichment for ESC-specific TFs, including Esrrb, Tcfap2c,
Zfp423, and Nr5a2. Many of these TFs were connected to the
maintenance of pluripotency and self-renewal. Cluster 4 sites
mainly included motifs of TFs (including members of the Elf
family, Yy1, and Nfya) that have been implicated in transcription
regulation through binding at proximal promoters. Notably, no
c-Myc motif was enriched in any of Oct4-binding site clusters,
and this is in line with c-Myc being outside of the core pluripo-
tency network (Orkin and Hochedlinger, 2011). Additionally, we
found that some of these TFs had an expression profile matching
the patterns of Oct4 occupancy (Figures 2G and S2G).
Taken together, our results suggest a spatiotemporally regu-
lated Oct4-binding pattern during reprogramming. Moreover,
Oct4 binding may be orchestrated by different sets of TFs at
different stages to execute distinct functions.
Epigenetic Landscape Presets a Context for Oct4
Binding
To addresswhat resulted in theOct4-binding patterns discussed
in previous sections, we next explored the chromatin structure
andDNAmethylation level of Oct4-binding sites. FAIRE is a tech-
nique that identifies open genomic regions (Giresi et al., 2007).
FAIRE sequencing (FAIRE-seq) reads of mouse embryonic fibro-
blast (MEF) (Wapinski et al., 2013) were enriched in the target
sites that Oct4 bound to at the beginning of reprogramming
(clusters 1, 4, 5, and 6), but they were depleted in clusters 2
and 3 to which Oct4 did not bind until the late stage (Figure 3A).
Conversely, FAIRE-seq reads of mouse ESC line R1 (Buecker
et al., 2014) were depleted in clusters 1, 5, and 6 but enriched
in clusters 2, 3, and 4. This indicates that Oct4 prefers binding
to locally open genomic regions. We further used MEF MNase-
seq reads (Teif et al., 2012) to calculate nucleosome occupancy
in Oct4-binding sites on day 0. All the sites were classified to ten
groups by a 10% interval of ascendingly sorted nucleosome
occupancy in MEFs. Intriguingly, Oct4 occupancy on day 1
was negatively correlated to nucleosome occupancy in MEFs
(Figure 3B). This suggests that the openness status in genomic
regions presets a context for and facilitates the initial Oct4 bind-
ing during reprogramming.
HM is an important factor that regulates chromatin structure.
To explore whether there is any relationship between HMs and
Oct4 binding, we calculated the signal of the key HMs on all
Oct4-binding sites and conducted correlation analysis between
each HM and Oct4 binding. We observed a positive correlation
between Oct4 occupancy and the active markers H3K4me3,
with a correlation coefficient median of 0.36, and H3K27ac,
with a correlation coefficient median of 0.46, but no correlation
between Oct4 binding and H3K27me3 (correlation coefficient
median of 0.19) (Figures 3C and S3A).
We further obtained normalized DNA methylation data at
MEFs and iPSCs (Lee et al., 2014) to examine DNA methylation1544 Cell Reports 14, 1540–1554, February 16, 2016 ª2016 The Authstatus on all Oct4-binding sites. We observed a significant
change in average DNA methylation level in cluster 1, 2, 3, and
7 sites between MEFs and iPSCs (Figure 3D), which was oppo-
site to Oct4 occupancy change in reprogramming. We further
defined Oct4 sites with at least 20% change in DNA methylation
level betweenMEFs and iPSCs. DNAmethylation may be impor-
tant for these sites. Among these sites, 83%of cluster 2 sites and
74% of cluster 3 sites exhibited decreases in DNA methylation
level in iPSCs compared to MEFs. Also, 78% of cluster 1 sites
and 71% of cluster 7 sites exhibited increases in DNA methyl-
ation level in iPSCs compared to MEFs (Figure S3B). We next
examined the DNA methylation level dynamic changes at the
selected Oct4-binding sites in clusters 2 and 3 at different time
points of reprogramming and found that DNA methylation levels
were negatively correlated with Oct4 occupancy (Figures 3E,
S3C, and S3D). This suggests that DNA methylation levels are
closely related to Oct4 binding in these target sites.
Dynamics of Oct4 Binding and Chromatin Remodeling in
Promoter Regions
Dynamic chromatin remodeling through H3K4me3 and
H3K27me3 changes during reprogramming has been investi-
gated extensively (Hussein et al., 2014; Polo et al., 2012). Overall,
our results of H3K4me3/H3K27me3 dynamics in promoter
regions were consistent with previous findings that extensive
chromatin remodeling occurred in promoter regions during re-
programming and that HM changes were closely coupled with
gene expression changes (Figures S4A and S4B).
Next, we questioned how Oct4 binding in promoter regions
regulates gene expression in coordination with chromatin re-
modeling. Auto-correlation analysis of Oct4 occupancy in pro-
moter regions across time points divided the reprogramming
process into three phases identical to those defined by expres-
sion profiles (Figures 1E and 4A). This suggests that Oct4-bind-
ing dynamics in promoters reflects the molecular kinetics of
reprogramming. We further focused on three groups of genes
on the basis of Oct4-binding dynamics in their promoters. First,
a majority of genes displayed relatively unchanged Oct4 binding
during reprogramming, and the promoters of these genes main-
tained a stable and high H3K4me3 level and lacked the
H3K27me3 mark (Figure 4B). Moreover, the expression levels
of these genes were much higher than the average of all genes
(Figure 4C). Gene Ontology (GO) analysis revealed that these
genes were enriched for DNA repair, cell-cycle, and RNA-pro-
cessing pathways, indicating that they maintained basic cellular
functions as housekeeping genes (Figure 4B). Second, Oct4 oc-
cupancy decreased in the promoters of a group of genes during
reprogramming in parallel with a decrease in H3K4me3 and a
slight increase in H3K27me3. As a result, expression levels of
these genes decreased (Figure 4D). GO analysis of this group
of genes identified ion transport, cell adhesion, regulation of
transcription, etc. Third, another group of genes gained Oct4
binding in their promoters during reprogramming. Accordingly,
the H3K4me3 level increased and the H3K27me3 level
decreased slightly. As a consequence, gene expressions
increased (Figure 4E). GO analysis of this group of genes
identified pluripotency, stem cell maintenance, etc. We
further showed that activation of early, intermediate, and lateors
Figure 3. Relationship between Oct4 Binding and Chromatin Structure
(A) The accessibility of each cluster of Oct4-binding sites and their flanking regions before (day 0) and at the end stage of reprogramming as measured by the
FAIRE-seq read count of MEF and ESC, respectively. The reads per kilobase of transcript per million mapped reads (RPKM) was scaled to 0–1 for comparison.
(B) The boxplot shows the Oct4-binding signal in Oct4-binding peaks grouped by nucleosome occupancy in MEFs.
(legend continued on next page)
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pluripotency genes was consistent with sequential Oct4 occu-
pancy in their promoter regions (Figures 4F, S4C, and S4D).
Overall, Oct4 binding in promoter regions was positively corre-
lated with H3K4me3 but negatively correlated with H3K27me3.
Oct4 dynamic binding and chromatin remodeling in promoter re-
gions are well coordinated to regulate gene expression.
Hyperdynamic Enhancers in Reprogramming
In addition to promoter regions, many Oct4 sites are located in
regions distal to TSSs. To explore Oct4-binding dynamics in
these regions, we identified 47,878–72,737 putative enhancers
at each time point of reprogramming based on the histone
mark H3K4me1. We further identified 5,710–20,968 active en-
hancers at each time point based on the H3K27ac mark as pre-
viously described (Creyghton et al., 2010; Figure S5A). This result
was consistent with the estimate in the previous genome-wide
studies that there may be1 million enhancers in all mammalian
genome, whereas only tens of thousands were active in one
given cell type (Bernstein et al., 2012; Heintzman et al., 2009;
Thurman et al., 2012). To explore state changes in enhancer
and the dynamics of Oct4 binding in enhancers in the reprogram-
ming process, we next merged enhancers and defined 158,946
enhancers during reprogramming (see Supplemental Experi-
mental Procedures). Thus, at any given reprogramming time
point, an individual enhancer was defined as having one of the
following three states: active (H3K4me1+ and H3K27ac+),
poised (H3K4me1+ only), or off (H3K4me1). Surprisingly,
99.2% of enhancers underwent state change during reprogram-
ming; 24.1%of themwent through all three states during reprog-
ramming, while 63.9% changed states between poised and off
(Figure 5A). Additional examination of enhancer state changes
between successive time points revealed that direct changes
between the active and off states were relatively rare.
Instead, the transition to the poised state was often involved in
a state change between the active and off states (Figures 5A
and S5B).
Emerging evidence has shown that epigenomic enhancer sig-
natures define cell identity and state, and that epigenetic
patterning of enhancers occurs prior to cell fate decisions during
development (Calo and Wysocka, 2013; Giresi et al., 2007; Liu
et al., 2011; Zhang et al., 2008). Therefore, we explored transi-
tions in active enhancers during reprogramming. Many MEF-
active enhancers rapidly became non-active in the first 7 days,
while only a small portion remained active (Figure 5B). Of the en-
hancers that were active inMEFs but non-active in iPSCs, 40.7%
and 27.7% first changed to de novo non-active on days 1 and 3,
respectively (Figure 5C). Moreover, the enhancers rarely
changed back to the active state during reprogramming once
they became de novo non-active (Figure 5D). In contrast, thema-
jority of iPSC-active enhancers did not became active until
day 15 (Figure 5B). Of the enhancers that were active in iPSCs
but non-active in MEFs, 11.7% and 58.4% became de novo
active on day 1 and in iPSCs, respectively (Figure 5E). Similarly,(C) Heatmaps of H3K4me3, H3K27ac, and H3K27me3 in each cluster of total Oc
(D) DNA methylation level in each cluster of Oct4-binding sites before (MEF) and
(E) Oct4 ChIP-seq binding profiles at a chosen genomic locus (left), and DNA me
examples are provided in Figure S3D.
1546 Cell Reports 14, 1540–1554, February 16, 2016 ª2016 The Authmost of the enhancers remained active once they became de
novo active. Their states did not switch back and forth (Fig-
ure 5F). Our results demonstrate for the first time that the erasure
of somatic cell memory occurs first and that the stem cell identity
is established subsequently, at the enhancer level, during
reprogramming.
Next, we used the Genomic Regions Enrichment of Annota-
tions Tool (GREAT) to analyze the functional significance of en-
hancers that display distinct epigenomic dynamics during
reprogramming. GO term analysis of the constantly poised en-
hancers identified enrichment for embryonic morphogenesis,
pattern specification, and regionalization, suggesting that these
enhancers are associated with early embryonic development
and cell differentiation (Figure S5C). We propose that the primed
yet inactivated state might be beneficial to permit a quick
response to differentiation cues. GO analysis of the constantly
active enhancers identified enrichment for fundamental
biological processes, such as actin filament organization, RNA
splicing, RNA processing, and cytoskeleton organization
(Figure S5D). Surprisingly, a cluster of enhancers that were inter-
mediately activated during reprogramming showed GO term
enrichment for histone acetylation, peptidyl-lysine acetylation,
and HM (Figure 5G). Consistent with the reported beneficial
effect conferred by the inhibition of histone deacetylases
(HDACi) on the transition from somatic cells or F-class cells to
iPSCs during reprogramming (Plath and Lowry, 2011; Tonge
et al., 2014), our results restated the importance of histone acet-
ylation during reprogramming. As expected, enhancers that
were activated late played roles mainly in the maintenance of
pluripotency (Figure 5G).
Dynamics of Oct4 Binding in Enhancer Regions during
Reprogramming
Oct4 bound to 38.3% (n = 60,864) of total enhancers during re-
programming. We grouped these enhancers into five clusters
(A–E) based on the Oct4-binding signal using K-means algorithm
(k = 5) (Figure 6A). The signals for key HMs (H3K27ac, H3K4me3,
and H3K27me3) and RNA Pol II binding in each enhancer also
were calculated. There was prominent positive correlation be-
tween Oct4 binding and H3K4me1, H3K27ac, H3K4me3, and
RNA Pol II signals, except for H3K27me3 (Figure S6A). A careful
examination of this correlation revealed that the presence of
H3K4me1 in enhancers preceded Oct4 binding, implying that
the H3K4me1 mark presets a context for Oct4 binding in
enhancers. However, the acquisition of H3K27ac on these en-
hancers was often accompanied by or lagged behind Oct4 bind-
ing. Hence, our data suggest that enhancer activation occurs in a
stepwise manner, first priming with the H3K4me1mark, followed
by TF binding, and subsequently the deposition of H3K27ac (Fig-
ure 6A). To help us understand the dynamics of Oct4 binding in
enhancers, we tracked the source of Oct4 binding on these
enhancers. Cluster A enhancers mainly contained cluster 4
Oct4 target sites, cluster C enhancers primarily included cluster 1t4-binding peaks. Peaks are shown in the same order.
at the end stage (iPSC) of reprogramming is shown (**p < 0.01).
thylation levels at the Oct4 peak at the indicated time points (right). More loci
ors
Figure 4. Crosstalk between Oct4 Binding and HMs in Promoter Regions
(A) Pairwise correlations of Oct4 signal in promoter regions at the indicated reprogramming time points are shown.
(B) Promoters with constant Oct4-binding signal immediately following reprogramming exhibited constantly high H3K4me3 levels and lacked H3K27me3 (left).
GO terms for the corresponding genes were enriched for housekeeping functions (right).
(C) Transcription levels of the genes in (B) were much higher than the average transcription level of all genes (red line) during reprogramming.
(D) Heatmap shows changes in the occupancy in ‘‘Oct4 loss’’ promoters of Oct4/H3K4me3/H3K27me3 and in the corresponding gene expression levels.
(E) The gradual gain of Oct4 signal in promoters was positively correlated with an increase in H3K4me3 occupancy.
(F) Oct4 signal in Nodal locus, an early pluripotency gene. The corresponding expression change of Nodal is shown in Figure S1B. More loci examples are
provided in Figures S4C and S4D.
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Figure 5. Dynamics of Enhancer Status along Reprogramming
(A) Enhancers switch between three states (A, active; P, poised; and O, off) during reprogramming. The pie chart summarizes the proportion of each enhancer
category.
(legend continued on next page)
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Oct4 target sites, and Oct4 sites in cluster E enhancers largely
consisted of cluster 2 and 3 Oct4 target sites (Figures S6B
and 2D).
We further performed functional annotation of these Oct4-
bound enhancers (Figure S6C). GO terms enriched in cluster A
enhancers included macromolecule methylation, actin filament
organization, histone methylation, and epigenetic regulation of
gene expression. Cluster B and C enhancers were enriched for
a variety of cell differentiation or organ development GO terms.
Notably, cluster D enhancers were annotated to kinase activity
regulation and multiple signaling pathways, including MAPK,
TGFb, and EGF. Because these signaling pathways have been
implicated in multiple mesodermal or endodermal lineage
induction processes, we speculate that Oct4 binding on these
enhancers is associated with its role as a lineage specifier
(Thomson et al., 2011; Wang et al., 2012). In addition, cluster E
enhancers that acquired Oct4 signal at the late stage of reprog-
ramming were enriched for stem cell-related pathways (Figures
6A and S6C).
We further profiled the histone mark H3K27ac and Oct4 bind-
ing in a set of super-enhancers (SEs) that are specific to ESCs
(Whyte et al., 2013). The results showed that both the
H3K27ac mark and Oct4 binding were gradually established in
a few SEs at the early stage (before day 7) of reprogramming,
that they rapidly occupied many SEs on day 11, and that they
occupied almost all SEs in iPSCs (Figures 6B and 6C). Together
with late Oct4 binding at cluster E enhancers, these data high-
light the function of Oct4 in the establishment and maintenance
of pluripotency at the late stage of reprogramming.
Hierarchical Oct4 Binding Facilitates the Establishment
of the Pluripotency Network during Reprogramming
Pluripotency was established through highly interconnected plu-
ripotency regulatory networks consisting of core and other TFs
(Orkin and Hochedlinger, 2011; Young, 2011). To address how
Oct4 binding in enhancers regulates the activation of pluripo-
tency networks, we collected member genes of the pluripotency
networks from published works (Apostolou and Hochedlinger,
2013; Buganim et al., 2013; Hussein et al., 2014; M€uller et al.,
2008; Polo et al., 2012). We defined these genes as pluripotency
network-related genes. Based on their expression profiles dur-
ing reprogramming, they were clustered into four groups as fol-
lows: constantly active, early activated, intermediately activated,
and late activated. Notably, the timing of Oct4 binding in their en-
hancers matched the timing of their transcriptional activation,
indicating a possible causative link (Figure 6D). This suggests
that Oct4 activates pluripotency networks in a hierarchical
manner through sequential binding.(B) Gradual loss of somatic cell-specific active enhancers and establishment o
number of active enhancers overlapping with MEF- and iPSC-specific active enh
respectively.
(C) The percentage of enhancers that are deactivated de novo at each indicated
(D) Heatmap shows state switches between active and non-active of the de nov
(E) The percentage of enhancers that are activated de novo at each indicated tim
(F) Heatmap shows state switches between active and non-active of the de nov
(G) Top heatmaps display H3K27ac signal in two clusters of enhancers: interme
enriched in the corresponding enhancers.
See also Figure S5.
Cell ROne gene can be regulated by multiple enhancers as well as
the promoter. To study how Oct4 binding in these regulatory el-
ements orchestrates the activation of downstream genes, we
used Nanog and Oct4 (also known as Pou5f1) as examples to
examine Oct4-binding status and key HM changes during re-
programming. Oct4 bound to these enhancers at different time
points. Moreover, Oct4 binding to the enhancers often preceded
its binding to the promoter. Oct4-binding status in the promoter
was tightly coupled with transcriptional activation. (Figures 6E
and S6E). Our data also imply that an additional layer of regula-
tion might exist between Oct4 binding to distal elements and
gene activation, such as enhancer-promoter looping, as has
been reported (Apostolou et al., 2013). Consistent with our re-
sults mentioned above, epigenetic remodeling concorded with
Oct4 binding. For example, H3K4me1 was deposited in the clas-
sical Nanog enhancer (E3, 4.5 kb upstream of TSS) in MEFs.
Oct4 bound to E3 as early as on day 1, and the H3K27ac signal
subsequently increased. In addition, the H3K27me3 signal
decreased and the H3K4me3 signal increased as Oct4 bound
to the Nanog promoter from day 7 (Figure S6D). Taken together,
our data demonstrate that hierarchical Oct4 binding to the regu-
latory elements is in accord with epigenetic rearrangements to
activate pluripotency gene expression during reprogramming.
DISCUSSION
Oct4 plays a central role in establishing and maintaining pluripo-
tency in ESCs and during somatic cell reprogramming. Here we
provide the first comprehensive roadmap of Oct4 binding
throughout the reprogramming process. Our data reveal that
Oct4 dynamically targets regulatory elements with distinct func-
tional themes at different stages of reprogramming (Figure 7).
Oct4 binds to a group of target sites from day 1 and maintains
a constant and high level of Oct4 occupancy throughout reprog-
ramming. These Oct4-binding sites reside predominantly within
the promoters of housekeeping genes. There is another group of
Oct4 target sites that are located mainly in regions distal to TSSs
and that have functions in development and differentiation. Oct4
occupies these sites during the early and intermediate stages of
reprogramming. Oct4 signals on these sites decrease dramati-
cally in parallel with the repression of somatic or lineage-specific
transcription programs. Oct4 begins binding to a set of target
sites at the intermediate or late stage of reprogramming and
maintains its stable occupancy. These sites are enriched in
both promoters and enhancers of pluripotency genes. Oct4
occupancy in these regulatory regions plays an important role
in the acquisition and maintenance of pluripotency during re-
programming (Figure 7). Moreover, our data indicate thatf pluripotent stem cell-specific active enhancers during reprogramming. The
ancers at the indicated reprogramming time points are shown in black and red,
time point during reprogramming is shown.
o deactivated enhancers at each time point.
e point during reprogramming is shown.
o activated enhancers at each time point.
diately and late activated. Bottom bar plots list biological process GO terms
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Figure 7. Model Depicting Dynamic Oct4
Binding in Concert with Epigenetic Changes
during Reprogramming
(Left) Hierarchical patterns of Oct4 binding in en-
hancers and promoters with transcriptional control
of distinct functional themes. (Right) Primed
epigenetic rearrangements (e.g., nucleosome oc-
cupancy, HMs, and DNAmethylation) give rise to a
permissive state for Oct4 binding that in turn fa-
cilitates local chromatin remodeling and, conse-
quently, activates the expression of target genes. If
there is a looping between enhancers and pro-
moters remains unknown.sequential Oct4 binding plays a critical role in the hierarchical
activation of pluripotency networks. The timing of initial Oct4
binding to promoters and enhancers is well matched to the
sequential activation of different pluripotency genes (Figures
4F, 6D, S4C, and S4D).
We used integrative analysis of Oct4-binding data, in addition
to epigenomic and transcriptomic data across the reprogram-
ming process, to systemically evaluate the interplay between
Oct4 binding and epigenetic remodeling and to explore how their
combined action controls downstream gene transcription. We
found that epigenetic rearrangements usually predispose a locus
to a permissive state for Oct4 binding. For instance, Oct4 initially
preferred to bind in open chromatin in MEFs, while condensed
chromatin, DNA methylation, or the deposition of H3K27me3
on a promoter impeded Oct4 targeting. Prior to Oct4 binding,
epigenetic rearrangements, including DNA demethylation and
enhancer priming by H3K4me1 deposition, enabled a permissive
environment. Subsequent Oct4 occupancy further activated the
local chromatin, as indicated by an increase in the active histone
marks H3K4me3 and H3K27ac. Overall, Oct4 bound to en-
hancersandpromoters of genesandactivatedgene transcription
in coordination with active epigenetic rearrangements (Figure 7).
Enhancers played important roles in the control of cell iden-
tity (Bulger and Groudine, 2011; Spitz and Furlong, 2012; Xie
and Ren, 2013). However, the study of enhancers in a contin-
uous and dynamic system is difficult because of the diversity
and complexity of enhancer states that exist in different cell
states. We have, for the first time, analyzed the hyperdynamic
enhancer signature transition during reprogramming. Intrigu-
ingly, somatic cell-specific enhancers were silenced in the
early stage of reprogramming, followed by activation of stem
cell-specific enhancers in the late stage, in parallel with the
cell fate transition. Previous studies have developed an alter-Figure 6. Hierarchical Oct4 Binding in Enhancers during Reprogramm
(A) Heatmaps of H3K4me1, Oct4 occupancy, H3K27ac, RNA Pol II, H3K4me3, a
clustering (k = 5) by Oct4 signal. Enhancers are displayed in the same order.
(B) H3K27ac signal in the ESC-specific super-enhancers (SEs) at indicated repro
(C) Oct4 signal in the SEs at indicated reprogramming time points is shown.
(D) Heatmaps showing transcription levels of four groups of pluripotency genes d
enhancers (right). The genes and the enhancers are in the same order.
(E) Schematic diagrams showing the transcriptional control of Oct4 binding in e
detailed ChIP-seq profiles are shown in Figures S6D and S6E.
Cell Rnative lineage conversion strategy in which cell identity transi-
tion is first through a plastic intermediate state, induced by
brief exposure to reprogramming factors, and followed by dif-
ferentiation. Several different cell types, including murine car-
diac and neuronal cells and human angioblast-like progenitor
cells, have been derived successfully using this approach
(Efe and Ding, 2011; Efe et al., 2011; Kim et al., 2011; Kurian
et al., 2013). In relation to enhancer signatures, our observa-
tions support the existence of this plastic intermediate state
in the intermediate reprogramming cells around day 7 and
11, which are the least like MEFs and iPSCs and have the
smallest number of active enhancers (Figures 5B and S5A).
Furthermore, our data confirm the importance of histone acet-
ylation during reprogramming via a new insight that the
activation of acetylation-related enhancers precedes that of
the pluripotency-related counterparts (Figure 5G). Our results
thus support the previously reported beneficial effect of HDACi
on reprogramming and F-class-to-iPSC transition (Plath and
Lowry, 2011; Tonge et al., 2014).
In summary, our study not only provides new insights into the
roadmap of Oct4 binding and its instructive roles in reprogram-
ming but also provides a rich data resource for further study of
mechanisms involved in somatic cell reprogramming. Compre-
hensive profiling is still required for the other three factors:
Sox2, Klf4, and c-Myc. Moreover, a careful examination of the
precise functional consequences of different TF-binding dy-
namics is currently lacking due to technical limitations. It will
be critical to study genomic architecture dynamics through cir-
cular chromatin conformation capture (4C)-based methods in
order to fill the gap between TF binding in regulatory elements
and transcription activation. Finally, the binding events detected
in our study byChIP-seqmay reflect only a general trend in a bulk
population, and we may have missed some key stochasticing
nd H3K27me3 in Oct4-bound enhancers that were clustered using K-means
gramming time points is shown.
uring reprogramming (left). Heatmaps display Oct4 signal in the corresponding
nhancers and promoters at Nanog and Oct4 (also known as Pou5f1) loci. The
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binding events that occur in the early stage. New technologies
and approaches will be required to study these processes at
the single-cell level in the future.
EXPERIMENTAL PROCEDURES
Animals
Mouse procedures were carried out according to the guidelines for the use of
laboratory animals of the National Institute of Biological Sciences (NIBS).
TetO-FUW-3FLAG-Oct4 Lentivirus Vector Construction and 1
Reprogramming
The Oct4 CDS was cloned from the TetO-FUW-Oct4 plasmid (Addgene
plasmid 20323) and inserted into PBS-N-strep-4FLAG backbone (a gift from
Yuelin Zhang, NIBS); the 3FLAG-Oct4 fragment was amplified by PCR and
cloned back into the TetO-FUW backbone. The 1 reprogramming was per-
formed as previously described, using inducible lentivirus vectors (Brambrink
et al., 2008; Kang et al., 2009; Stadtfeld et al., 2008). When GFP-positive col-
onies appeared 2 weeks after Dox and Vc induction, ten iPS colonies were
picked and propagated after Dox withdrawal.
Tetraploid Complementation Assay
The tetraploid complementation assay was performed as previously described
(Kang et al., 2009). Two-cell stage B6D2F1 embryos were electrofused and
cultured toblastocyst stage in vitro.Approximately10–15 iPScellswere injected
into the cavities of tetraploid blastocysts. The complemented blastocysts were
then transplanted into pseudo-pregnant ICR recipients. MEFs (20) were derived
from embryonic day (E)13.5 embryos and genotyped for cell origin.
Flow Cytometry
Reprogramming cells were harvested and incubated with antibodies against
Thy1.2 (PE/Cy7, BioLegend) and SSEA1 (AlexaFluor647, BioLegend). Flow
cytometry analyses for GFP, Thy1, and SSEA1 were performed as previously
described (Gao et al., 2013).
ChIP
Reprogramming cells were collected at different time points, crosslinked, and
sonicated. Sonicated chromatin was incubated with pretreated antibody-
coupled Protein G Dynabeads (Invitrogen) at 4C overnight. Antibodies used
in ChIP assays and other experiments are listed in Table S1. ChIP DNA was
reverse-crosslinked, eluted, and purified by phenol-chloroform-isoamyl
alcohol extraction, followed by ethanol precipitation. ChIP DNA was then
quantified using a Qubit dsDNA HS assay kit (Life Technologies). We per-
formed two or three independent IP reactions for each sample, and ChIP
DNA was pooled for library preparation. For sequencing, 10–100 ng DNA
was used for library preparation following the New England Biolabs library
preparation protocol.
ChIP-Seq
ChIP products were subjected to high-throughput sequencing with HiSeq
2000/HiSeq 2500 sequencer using a 50-bp SE protocol.
DNA Methylation Analysis by Bisulfite Sequencing
Genomic DNA was extracted using a TIANamp Genomic DNA Kit (TIANGEN)
and bisulfite converted with an EpiTect Bisulfite Kit (QIAGEN). Methylation
PCR primers were designed by MethPrimer and data analysis was performed
using QUMA (Kumaki et al., 2008; Li and Dahiya, 2002).
RNA Profiling
Gene expression profiling was performed using Affymetrix Mouse Gene 1.0 ST
arrays. Microarray datasets were preprocessed and quantile normalized with
the robust multi-array average (RMA) method.
Analysis of Global Oct4 Occupancy
After Oct4 ChIP-seq reads were mapped to mouse genome, we calculated
FLAG and total Oct4 occupancy by scanning the genome with a 1-kb sliding1552 Cell Reports 14, 1540–1554, February 16, 2016 ª2016 The Authwindow for correlation analysis at distinct time points. We called Oct4-binding
peaks at each time point that were furthermerged as the final set of Oct4-bind-
ing sites in this study. FAIRE-seq and MNase-seq reads mapped in each site
were counted to measure the accessibility of Oct4 sites. The signals of HMs in
Oct4 sites were calculated in a similar manner. We further correlated the HM
signals with Oct4 occupancy in the sites.
Oct4 Binding and HMs in Promoters and Enhancers
Gene promoters were defined as 1.5 kb to +0.5 kb of gene TSSs. Read
counts of HMs and Oct4 in promoters defined their signal intensity that was
used to analyze their dynamic changes in reprogramming. H3K4me1 peaks
were called in a way similar to Oct4 peaks and defined enhancers excluding
those overlapped with promoters. All enhancers of distinct time points were
merged as the final set of enhancers in this study. Signals of Oct4, HMs, and
RNA Pol II in an enhancer were calculated to define its activation state, analyze
correlation and dynamic changes, and so forth.
Hierarchical Activation Analysis of Pluripotency Genes throughOct4
Binding in Enhancers
Pluripotency genes were downloaded through literature mining. We clustered
the genes based on their expression profiles, and we further correlated Oct4
occupancy in their enhancers and their expression levels in reprogramming.
See the Supplemental Experimental Procedures for more detailed methods.
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